Cargando…
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX
During tumor invasion, tumor cells degrade the extracellular matrix. Basement membrane degradation is responsible for the production of peptides with anti-tumor properties. Type XIX collagen is associated with basement membranes in vascular, neuronal, mesenchymal and epithelial tissues. Previously,...
Autores principales: | Oudart, Jean-Baptiste, Brassart-Pasco, Sylvie, Vautrin, Alexia, Sellier, Christèle, Machado, Carine, Dupont-Deshorgue, Aurelie, Brassart, Bertrand, Baud, S., Dauchez, Manuel, Monboisse, Jean-Claude, Harakat, Dominique, Maquart, François-Xavier, Ramont, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414144/ https://www.ncbi.nlm.nih.gov/pubmed/25668817 |
Ejemplares similares
-
The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction
por: Oudart, Jean-Baptiste, et al.
Publicado: (2015) -
F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction
por: Oudart, Jean-Baptiste, et al.
Publicado: (2021) -
Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV
por: Vautrin-Glabik, Alexia, et al.
Publicado: (2020) -
Conformation-dependent binding of a Tetrastatin peptide to α(v)β(3) integrin decreases melanoma progression through FAK/PI(3)K/Akt pathway inhibition
por: Lambert, Eléonore, et al.
Publicado: (2018) -
Extracellular Vesicle-Dependent Cross-Talk in Cancer—Focus on Pancreatic Cancer
por: Nannan, Lise, et al.
Publicado: (2020)